« Back
Home /
MLN9708

MLN9708

Item no.	M2122-50mg
Manufacturer	AbMole
CASRN	1239908-20-3
Amount	50mg
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Lymphatic System Cancer
Type	Inhibitors
Specific against	other
Purity	0,9982
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	ixazomib citrate
Similar products	MLN9708
Available
Target Information	Proteasome
Molecular Weight	517, 12
Solubility	DMSO: ≥ 90 mg/mL
Bioactivity information	MLN9708 is a novel orally bioactive proteasome inhibitor, inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasome with an IC50 value of 3.4 nM.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M2122-50mg-safety-datasheet.pdf